相关实验视频

Updated: Jan 17, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

开发一个人工智能驱动的药物风险评分计算器应用程序

Ádám Bertalan¹, Viola Angyal¹, Péter Domján²

¹Institute of Digital Health Sciences, Health Sciences Division, Doctoral College, Semmelweis University, Budapest, Hungary.

Basic & clinical pharmacology & toxicology

|September 22, 2025

概括

增强药物风险评分 (AUGMERIS) 计算器使用人工智能自动化药物风险评估,提高患者安全. 该工具通过分析药物组合和功能,帮助全球识别高风险患者.

科学领域:

药理学药理学是指药理学的学科.
人工智能的人工智能
医疗信息学医疗信息学

背景情况:

临床药剂师在评估复杂的药物治疗和识别高风险患者方面面临着挑战.
为药物风险评估处理非结构化电子健康记录 (EHR) 是一个重大障碍.
现有的方法可能无法有效地将药物相互作用和功能 (例如,eGFR) 整合到风险得分中.

研究的目的:

开发和验证增强型药物风险评分 (AUGMERIS) 计算器,这是一个由人工智能驱动的网络应用程序.
通过使用丹麦药物风险评分 (MERIS) 方法自动化药物治疗的评估.
创建一个全球可访问的工具,用于识别需要药物审查的患者.

主要方法:

开发了一种混合文本处理模型,将传统算法与生成预训练变压器 (GPT) 技术相结合.
将文本处理模型和自动化风险计算集成到一个使用Python 3和Streamlit.的Web应用程序中.
通过8个国家的志愿测试人员的数据验证了应用程序的性能.

主要成果:

AUGMERIS 网络应用程序成功地自动化了药物风险评估,整合了药物组合和eGFR.
混合文本处理模型有效地处理非结构化的EHR数据,用于风险评估.
志愿测试人员进行了383次试验计算,尽管存在验证限制,但表现令人满意.

结论:

AUGMERIS计算器有可能显著改善全球药物治疗和患者安全.
更广泛地采用AUGMERIS可以提高药物评价,并优化跨不同医疗保健系统的治疗.
该工具展示了在临床实践中使用人工智能进行自动化药物风险评估的可行性.

关键词:

人工智能的人工智能是人工智能.临床药房临床药房数据挖掘是数据挖掘的一个方法.决策支持提供了决策支持.药物使用风险药物使用风险

更多相关视频

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

相关概念视频

Issues And Trends In Healthcare Delivery System

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...